Literature DB >> 10988139

Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis.

D A Vassilakis1, G Sourvinos, D A Spandidos, N M Siafakas, D Bouros.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology associated with DNA damage and malignancy. Bronchogenic carcinoma is the cause of death in 10% to 13% of IPF patients. Microsatellite instability (MSI) and loss of heterozygosity (LOH) are frequently detected in cancers. If these genetic alterations could be observed in IPF, they might explain the higher relative risk of lung cancer in this disease. We investigated the incidence of MSI and LOH in sputum cytologic specimens from 26 IPF patients and 26 healthy, matched subjects, using 10 highly polymorphic microsatellite markers. The electrophoretic pattern of each specimen was compared with that of corresponding peripheral blood. Thirteen (50%) patients showed genetic alterations, consisting either of MSI or LOH. Five (19%) patients exhibited MSI and 10 (39%) exhibited LOH in at least one microsatellite marker. Three (12%) patients showed LOH in more than one marker. None of the healthy subjects exhibited genetic alterations in the studied markers. No correlation was found between the detected genetic alterations and age, disease duration, blood gases, or spirometric parameters of the patients. Our findings suggest that the genetic alterations that we studied are frequent in IPF, are apparently unrelated to the severity of the disease, and may be related to tumorigenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10988139     DOI: 10.1164/ajrccm.162.3.9911119

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

Review 1.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

2.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

Authors:  Imre Noth; Yingze Zhang; Shwu-Fan Ma; Dan Nicolae; Naftali Kaminski; Joe G N Garcia; Carlos Flores; Mathew Barber; Yong Huang; Steven M Broderick; Michael S Wade; Pirro Hysi; Joseph Scuirba; Thomas J Richards; Brenda M Juan-Guardela; Rekha Vij; MeiLan K Han; Fernando J Martinez; Karl Kossen; Scott D Seiwert; Jason D Christie
Journal:  Lancet Respir Med       Date:  2013-04-17       Impact factor: 30.700

3.  Genetic analysis of sporadic and familial interstitial pneumonia.

Authors:  David A Schwartz
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 4.  Mechanistic links between aging and lung fibrosis.

Authors:  Victor J Thannickal
Journal:  Biogerontology       Date:  2013-08-09       Impact factor: 4.277

5.  Idiopathic pulmonary fibrosis and cancer: do they really look similar?

Authors:  Carlo Vancheri
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

6.  Pulmonary adenocarcinoma mutation profile in smokers with smoking-related interstitial fibrosis.

Authors:  Andrea Primiani; Dora Dias-Santagata; A John Iafrate; Richard L Kradin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-24

7.  miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.

Authors:  Eleni Bibaki; Eliza Tsitoura; Eirini Vasarmidi; George Margaritopoulos; Athina Trachalaki; Chara Koutoulaki; Theodora Georgopoulou; Demetrios A Spandidos; Nikos Tzanakis; Katerina M Antoniou
Journal:  Mol Med Rep       Date:  2018-03-19       Impact factor: 2.952

Review 8.  Measuring Surgery Outcomes of Lung Cancer Patients with Concomitant Pulmonary Fibrosis: A Review of the Literature.

Authors:  Taichiro Goto
Journal:  Cancers (Basel)       Date:  2018-07-04       Impact factor: 6.639

9.  Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Authors:  Tanzira Zaman; Joyce S Lee
Journal:  Curr Pulmonol Rep       Date:  2018-10-16

10.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.